Literature DB >> 12553420

The evolution of transthyretin synthesis in the choroid plexus.

Gerhard Schreiber1.   

Abstract

Choroid plexus has the highest concentration of transthyretin (TTR) mRNA in the body, 4.4 microg TTR mRNA/g wet weight tissue, compared with 0.39 microg in the liver. The proportion of TTR to total protein synthesis in choroid plexus is 12%. All newly synthesized TTR is secreted towards the ventricles. Net transfer of T4 occurs only towards the ventricle and depends on ongoing protein synthesis. Thyroxine-binding globulin (TBG), TTR and albumin form a "buffering" system for plasma [T4] because of their overlapping affinities and on/off rates for L-thyroxine (T4)-binding. The individual components of this network determining T4 distribution are functionally highly redundant. Absence of TBG (humans), or TTR (mice), or albumin (humans, rats) is not associated with hypothyroidism. Natural selection is based on small, inheritable alterations improving function. The study of these alterations can identify function. TTR genes were cloned and sequenced for a large number of vertebrate species. Systematic, stepwise changes during evolution occurred only in the N-terminal region, which became shorter and more hydrophilic. Simultaneously, a change in function occurred: TTR affinities for T4 are higher in mammals than in reptiles and birds. L-triiodothyronine (T3) affinities show the opposite trend. This favors site-specific regulation of thyroid hormones by tissue-specific deiodinases in the brain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12553420     DOI: 10.1515/CCLM.2002.210

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  10 in total

1.  Targeting the choroid plexus-CSF-brain nexus using peptides identified by phage display.

Authors:  Andrew Baird; Brian P Eliceiri; Ana Maria Gonzalez; Conrad E Johanson; Wendy Leadbeater; Edward G Stopa
Journal:  Methods Mol Biol       Date:  2011

2.  Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis.

Authors:  Srikanth Ranganathan; Eric Williams; Philip Ganchev; Vanathi Gopalakrishnan; David Lacomis; Leo Urbinelli; Kristyn Newhall; Merit E Cudkowicz; Robert H Brown; Robert Bowser
Journal:  J Neurochem       Date:  2005-12       Impact factor: 5.372

3.  Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences.

Authors:  Zoran Redzic
Journal:  Fluids Barriers CNS       Date:  2011-01-18

4.  Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicity.

Authors:  Joel N Buxbaum; Zhengyi Ye; Natàlia Reixach; Linsey Friske; Coree Levy; Pritam Das; Todd Golde; Eliezer Masliah; Amanda R Roberts; Tamas Bartfai
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-12       Impact factor: 11.205

5.  Cobalamin (vitamin B12)-deficiency-induced changes in the proteome of rat cerebrospinal fluid.

Authors:  Elisabetta Gianazza; Daniela Veber; Ivano Eberini; Francesca R Buccellato; Elena Mutti; Luigi Sironi; Giuseppe Scalabrino
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

6.  Substrate specificity of transthyretin: identification of natural substrates in the nervous system.

Authors:  Márcia A Liz; Carolina E Fleming; Ana F Nunes; Maria R Almeida; Fernando M Mar; Youngchool Choe; Charles S Craik; James C Powers; Matthew Bogyo; Mónica M Sousa
Journal:  Biochem J       Date:  2009-04-15       Impact factor: 3.857

Review 7.  Plasma Transthyretin as a Biomarker of Lean Body Mass and Catabolic States.

Authors:  Yves Ingenbleek; Larry H Bernstein
Journal:  Adv Nutr       Date:  2015-09-15       Impact factor: 8.701

8.  Vitreous amyloidosis with autonomic neuropathy of the digestive tract associated with a novel transthyretin p.Gly87Arg variant in a Bangladeshi patient: a case report.

Authors:  Benjamin Terrier; Magali Colombat; Caroline Beugnet; Astrid Quéant; Jonathan London; Jean-Baptiste Daudin; Claire Le Jeunne; Luc Mouthon; Dominique Monnet; Cécile Cauquil; Catherine Lacroix; David Adams; Antoine Brézin; Sophie Valleix
Journal:  J Med Case Rep       Date:  2017-08-13

9.  Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13.

Authors:  Nilufer Esen; Emily K Rainey-Barger; Amanda K Huber; Pennelope K Blakely; David N Irani
Journal:  Glia       Date:  2014-05-14       Impact factor: 7.452

Review 10.  Ocular Involvement in Hereditary Amyloidosis.

Authors:  Angelo Maria Minnella; Roberta Rissotto; Elena Antoniazzi; Marco Di Girolamo; Marco Luigetti; Martina Maceroni; Daniela Bacherini; Benedetto Falsini; Stanislao Rizzo; Laura Obici
Journal:  Genes (Basel)       Date:  2021-06-22       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.